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Abstract
Evidence-based information for nurses on the risks and benefits of prescription opioids.
The United States is in the midst of an opioid overdose epidemic. Between 1999 and 2010, 
prescription opioid–related overdose deaths rose dramatically, in parallel with increased 
opioid prescribing.1 In 2015, more than 40 people died each day from an overdose involving 
prescription opioids.2
In July 2017, the Centers for Disease Control and Prevention (CDC) released Vital Signs: 
Changes in Opioid Prescribing in the United States, 2006–2015.3 The report revealed that 
the amount of opioids (measured in morphine milligram equivalents) prescribed per person 
peaked in 2010 and subsequently decreased each year through 2015. These reductions might 
be attributed to the growing awareness among both health care providers and patients of the 
risks associated with prescription opioids. An-other key finding in the report was the 
substantial variation in opioid prescribing across the country. In 2015, providers in the 
highest prescribing counties prescribed six times more opioids per person than providers in 
the lowest prescribing counties (see Figure 1).
The substantial variation in opioid prescribing suggests a lack of consensus regarding the 
appropriate use of opioids. Health care providers play an important role in ensuring safer 
and more effective opioid prescribing. The CDC Guideline for Prescribing Opioids for 
Chronic Pain—United States, 2016 provides evidence-based recommendations about opioid 
prescribing for adult patients with chronic pain outside of active cancer treatment, palliative 
care, and end-of-life care.4 An online training series is available from the CDC to help 
health care providers apply these recommendations. Participants can receive free continuing 
education (CME, CNE, or CEU) and gain a better understanding of the recommendations, 
the risks and benefits of prescription opioids, nonopioid treatment options, patient 
communication strategies, and risk mitigation. More information on the training series is 
available at www.cdc.gov/drugoverdose/training/index.html.
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Nurses and other health care providers can educate patients on the risks and benefits of 
prescription opioids so that together they can make informed decisions about care. With that 
in mind, the CDC has developed materials, including fact sheets, infographics, and posters, 
providers can use to provide patient education on the guideline and on the benefits and 
harms of opioid use (see www.cdc.gov/drugoverdose/prescribing/clinical-tools.html). The 
CDC has also developed a communications campaign aimed at improving awareness of the 
dangers of prescription opioids (www.cdc.gov/RxAwareness). This campaign features 
personal testimonials, images, and powerful messages that reveal the potential consequences 
of misusing prescription opioids. Unmasking the dangers of opioid use disorder and opioid 
overdose helps increase population-level understanding of the inherent risks of opioids, deter 
inappropriate use, and improve communication between health care providers and patients.
Health care professionals can help prevent opioid use disorder, overdose, and death by 
improving opioid prescribing as part of a coordinated public health effort. For more 
information on the Vital Signs report, go to www.cdc.gov/vitalsigns/opioids/index.html.
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Figure 1. 
The amount of opioids prescribed per person among U.S. counties in 2015. Image courtesy 
of the Centers for Disease Control and Prevention.
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